iBio, Inc. Announces Postponement of Annual Meeting
February 06, 2020 16:30 ET
|
iBio, Inc.
NEW YORK, Feb. 06, 2020 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”), today announced that the 2019 annual meeting of stockholders (the “Annual Meeting”) originally...
iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine
February 03, 2020 16:15 ET
|
iBio, Inc.
NEW YORK, Feb. 03, 2020 (GLOBE NEWSWIRE) -- In response to investor and media inquiries regarding their initiatives to address the coronavirus outbreak, iBio, Inc. (NYSE AMERICAN:IBIO) and Beijing...
iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance
January 16, 2020 08:00 ET
|
iBio, Inc.
NEW YORK, Jan. 16, 2020 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”), today announced that it has received notice from NYSE American LLC (the “Exchange”) that NYSE...
iBio Initiates New Litigation Against Fraunhofer
January 07, 2020 02:00 ET
|
iBio, Inc.
NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio”), a biologics innovator and contract manufacturer, announced today that it filed a motion in the Court of Chancery...
iBio Initiates New Litigation Against Fraunhofer
January 06, 2020 09:15 ET
|
iBio, Inc.
NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio”), a biologics innovator and contract manufacturer, announced today that it filed a motion in the Court of Chancery...
iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing
December 23, 2019 08:30 ET
|
iBio, Inc.
NEW YORK, Dec. 23, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has entered into a collaboration with EdgePoint AI, a division of Mateon Therapeutics, Inc....
iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming
December 16, 2019 16:15 ET
|
iBio, Inc.
- Presentation Demonstrates Advantages of iBio’s Recently Launched FastGlycaneering Development Service™ - NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) presented...
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
December 13, 2019 17:00 ET
|
iBio, Inc.
NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE American: IBIO) (“iBio” or the “Company”), a leader in plant-based biologics manufacturing, announced today that on December 9, 2019, the...
iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production
December 10, 2019 16:44 ET
|
iBio, Inc.
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today unveiled the FastGlycaneering Development Service™, which includes an array of new glycosylation technologies for...
iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative
December 03, 2019 12:31 ET
|
iBio, Inc.
NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it is now part of a new public-private Manufacturing USA initiative, the Advanced Regenerative...